HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guselkumab dosing interval optimization in adult patients with psoriasis: A retrospective, multicenter case series.

AuthorsAsfandyar Mufti, Khalad Maliyar, Laura Walton, Ronald Vender, Jensen Yeung
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 83 Issue 6 Pg. 1813-1814 (Dec 2020) ISSN: 1097-6787 [Electronic] United States
PMID32289394 (Publication Type: Letter, Multicenter Study)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • guselkumab
Topics
  • Adult
  • Aged
  • Antibodies, Monoclonal, Humanized (administration & dosage, adverse effects)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Humans
  • Injections, Subcutaneous
  • Male
  • Middle Aged
  • Psoriasis (diagnosis, drug therapy)
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: